Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Repurchase of Common Stock

Arena Pharmaceuticals Repurchase of Common Stock Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Repurchase of Common Stock from 2000 to 2003.
  • Arena Pharmaceuticals Repurchase of Common Stock for the quarter ending December 12, 2003 was $-23m
  • Arena Pharmaceuticals Repurchase of Common Stock for the last 12 months ending September 09, 2004 was $-23m a 0.00% decrease of 0m year over year
Other Cash Flow Metrics:
  • Arena Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-31m a 40.98% decrease of -13m year over year
  • Arena Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-18m a 99.28% decrease of -18m year over year
  • Arena Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $4m a -330.00% decrease of -12m year over year
View Chart On Koyfin

Quarterly ARNA Repurchase of Common Stock Data

12/2003$-23m
12/2000$0m

Annual ARNA Repurchase of Common Stock Data

2003$-23m